Related Experiment Videos

Inflammatory markers in essential hypertension: potential clinical implications

Elli Stefanadi1, Dimitris Tousoulis, Emmanuel S Androulakis

  • 11st Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece.

Current Vascular Pharmacology
|June 23, 2009
PubMed

Insights

Inflammation plays a key role in essential hypertension and cardiovascular disease. Evaluating inflammatory markers may guide treatment and improve outcomes for hypertension patients.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Hypertension Research

Background:

  • Inflammation is increasingly recognized in essential hypertension pathogenesis.
  • Key inflammatory markers like C-reactive protein and adhesion molecules are linked to hypertension risk.
  • These markers may predict pharmacologic responses and patient outcomes.

Purpose of the Study:

  • To review the role of inflammatory mechanisms in essential hypertension.
  • To highlight the clinical significance of inflammatory markers in hypertension management.
  • To discuss potential therapeutic strategies targeting inflammation.

Main Methods:

  • Literature review of recent studies on inflammation and hypertension.
  • Analysis of inflammatory markers (e.g., CRP, ICAM-1, VCAM-1) and their association with hypertension.
  • Discussion of current and potential therapeutic interventions.

Main Results:

  • Elevated levels of inflammatory markers are associated with increased hypertension risk.
  • Specific inflammatory molecules are implicated in cardiovascular disease progression.
  • Targeting inflammation alongside blood pressure reduction may offer clinical benefits.

Conclusions:

  • Inflammatory mechanisms are crucial in essential hypertension.
  • Assessment of inflammatory markers can inform treatment strategies.
  • Further randomized trials are needed to confirm the benefits of anti-inflammatory therapies in hypertension.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...